Not applicableStudy completedNCT02679417What this trial is testingThe Effects of Type of Exercise in Non-alcoholic Fatty Liver DiseaseWho this might be right forNon-alcoholic Fatty Liver Disease Mahidol University 38
Not applicableStudy completedNCT02083367What this trial is testingDefault Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy OutcomeWho this might be right forHepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more OSF Healthcare System 12
Not applicableStudy completedNCT03198104What this trial is testingAssessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRIWho this might be right forNon-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more Perspectum 35
Testing effectiveness (Phase 2)Looking for participantsNCT06588699What this trial is testingDigoxin In NASH (CODIN)Who this might be right forNASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more Yale University 144
Not applicableUnknownNCT05971082What this trial is testingRisk Factors for Advanced Fibrosis Among FLD PatientsWho this might be right forNAFLDLiver CirrhosisDiabetes Mellitus, Type 2 Helsinki University Central Hospital 1,000
Not applicableLooking for participantsNCT07294963What this trial is testingImpact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver DiseaseWho this might be right forNon-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders Khyber Medical University Peshawar 45
Not applicableLooking for participantsNCT04036357What this trial is testingLiver Damage and Cardiometabolic Disorders in NAFLDWho this might be right forNAFLDLiver FibrosesCardiovascular Diseases+1 more University of Roma La Sapienza 2,000
Not applicableLooking for participantsNCT05257200What this trial is testingGut Permeability and Bariatric-metabolic SurgeryWho this might be right forNASH - Nonalcoholic SteatohepatitisBariatric Surgery CandidateIntestinal Permeability Medical University of Vienna 125
Large-scale testing (Phase 3)Study completedNCT00244569What this trial is testingDevelopment of a Breath Test for Monitoring Patients With Liver DiseaseWho this might be right forFatty LiverCirrhosis Virginia Commonwealth University 120
Not applicableStudy completedNCT05383456What this trial is testingThe Visceral Adiposity Measurement and Observation StudyWho this might be right forHIVHIV-InfectionsHIV-1-infection+16 more Theratechnologies 196
Testing effectiveness (Phase 2)Ended earlyNCT01672866What this trial is testingSafety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)Who this might be right forLiver Fibrosis Due to NASH Gilead Sciences 222
Testing effectiveness (Phase 2)Ended earlyNCT02029586What this trial is testingTherapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except CirrhosisWho this might be right forNonalcoholic Fatty Liver Disease Yungjin Pharm. Co., Ltd. 18
Post-approval studies (Phase 4)Looking for participantsNCT06523530What this trial is testingEffect of a GnRH Analog on Hepatic SteatosisWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis Aristotle University Of Thessaloniki 62
Testing effectiveness (Phase 2)Ended earlyNCT04267393What this trial is testingSafety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)Who this might be right forNonalcoholic Steatohepatitis (NASH) Bristol-Myers Squibb 124
Early research (Phase 1)Study completedNCT04857437What this trial is testingStudy in Healthy Adults Evaluating PF-07202954Who this might be right forNon-Alcoholic Fatty Liver DiseaseLiver Fibrosis Pfizer 12
Not applicableLooking for participantsNCT04690972What this trial is testing"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".Who this might be right forChronic Liver Disease and CirrhosisLiver CancerNon-Alcoholic Fatty Liver Disease+4 more Institut National de la Santé Et de la Recherche Médicale, France 800
Not applicableActive Not RecruitingNCT06842563What this trial is testingHepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical TrialWho this might be right forHepatocellular Carcinoma (HCC) Singlera Genomics Inc. 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT05402371What this trial is testingEvaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisWho this might be right forNonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD Hepion Pharmaceuticals, Inc. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465186What this trial is testingA Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)Who this might be right forNon-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more Merck Sharp & Dohme LLC 80
Not applicableLooking for participantsNCT02206841What this trial is testingEstablishment of NAFLD Cohort and Development of Fibrosis MarkersWho this might be right forFibrosis of Liver Seoul National University Boramae Hospital 1,000